Literature DB >> 26375728

The value of histopathological examination of salivary gland biopsies in diagnosis, prognosis and treatment of Sjögren's Syndrome.

Francesca Barone1, Joana Campos1, Simon Bowman1, Benjamin A Fisher.   

Abstract

Primary Sjögren's syndrome (pSS) is a complex autoimmune disease characterised by local exocrine glandular involvement and systemic multiorgan manifestations. In this review we will discuss the value of the histological examination of the salivary glands in the classification criteria, and more recently as prognostic tool for patient stratification and monitoring. The limitations of the current tools used to assess salivary gland pathology in pSS will also be reviewed in relation to using salivary gland biopsy analysis as an outcome measure in clinical trials.

Entities:  

Mesh:

Year:  2015        PMID: 26375728     DOI: 10.4414/smw.2015.14168

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  9 in total

1.  Cerebellar degeneration in primary Sjӧgren syndrome.

Authors:  Mohammad Heidary; Samira Alesaeidi; Khashayar Afshari
Journal:  BMJ Case Rep       Date:  2018-06-06

Review 2.  Evaluation of the oral component of Sjögren's syndrome: An overview.

Authors:  Georges Aoun; Ibrahim Nasseh; Antoine Berberi
Journal:  J Int Soc Prev Community Dent       Date:  2016 Jul-Aug

3.  Immunophenotypes and clinical features of lymphocytes in the labial gland of primary Sjogren's syndrome patients.

Authors:  Wenwen Sun; Na Zhang; Yujie Zhang; Zonghong Shao; Lu Gong; Wei Wei
Journal:  J Clin Lab Anal       Date:  2018-06-19       Impact factor: 2.352

4.  Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.

Authors:  Saba Nayar; Joana Campos; Charlotte G Smith; Valentina Iannizzotto; David H Gardner; Serena Colafrancesco; Elena Pipi; Florian Kollert; Kelly J Hunter; Charlotte Brewer; Christopher Dominic Buckley; Simon J Bowman; Roberta Priori; Guido Valesini; Maria Juarez; William A Fahy; Benjamin A Fisher; Andrew Payne; Rodger A Allen; Francesca Barone
Journal:  Ann Rheum Dis       Date:  2018-11-24       Impact factor: 19.103

5.  Management of rheumatic complications of immune checkpoint inhibitor therapy - an oncological perspective.

Authors:  Neil M Steven; Benjamin A Fisher
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

Review 6.  Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

Authors:  Amrita Srivastava; Helen P Makarenkova
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

7.  Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome.

Authors:  Estelle Gerossier; Saba Nayar; Mark J Murphy; Marianne M Martinic; Francesca Barone; Sylvie Froidevaux; Charlotte G Smith; Celine Runser; Valentina Iannizzotto; Enrico Vezzali; Gabin Pierlot; Ulrich Mentzel
Journal:  Arthritis Res Ther       Date:  2021-11-29       Impact factor: 5.156

8.  A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren's syndrome.

Authors:  M Paula Gomez Hernandez; Emily E Starman; Andrew B Davis; Miyuraj Harishchandra Hikkaduwa Withanage; Erliang Zeng; Scott M Lieberman; Kim A Brogden; Emily A Lanzel
Journal:  Rheumatology (Oxford)       Date:  2021-10-02       Impact factor: 7.580

Review 9.  Biological Therapy in Primary Sjögren's Syndrome: Effect on Salivary Gland Function and Inflammation.

Authors:  Farzana Chowdhury; Anwar Tappuni; Michele Bombardieri
Journal:  Front Med (Lausanne)       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.